Department of Epidemiology, University of Florida, Gainesville, FL, USA.
Department of Epidemiology, University of Florida, Gainesville, FL, USA.
J Psychiatr Res. 2018 Dec;107:73-78. doi: 10.1016/j.jpsychires.2018.10.006. Epub 2018 Oct 5.
There are a growing number of mobile apps available for monitoring and management of mental health symptoms or disorders. However, clinically validated evidence for most of them is unclear; their benefits to patients on long term use are thus debatable.
This updated review aimed to systematically appraise the available research evidence of the efficacy and acceptability of mobile apps for mental health in all ages.
A comprehensive literature search (May 2013 to December 2017) in PubMed, Cochrane Library, EMBASE, Web of Science, and Google Scholar was conducted. Abstracts were included if they described mental health apps (targeting depression, anxiety, bipolar disorder, psychosis, post-traumatic stress disorders (PTSD), substance use disorders, sleep disorders, and suicidal behaviors) delivered on mobile devices for all ages.
In total, 1501 abstracts were identified. Of these, 17 publications describing 16 apps targeting anxiety/stress, alcohol disorder, sleep disorder, depression, suicidal behaviors, and PTSD met the inclusion criteria. Five studies randomized individuals to trial conditions, and 14 apps were proven to have clinically validated evidence in reducing mental health symptoms or disorder.
Mental health apps have potentials in improving the monitoring and management of mental health symptoms or disorders. However, majority of the apps that are currently available lack clinically validated evidence of their efficacy. Given the number and pace at which mobile Health (mHealth) apps are being released, further robust research is warranted to develop and test evidence-based programs.
目前有越来越多的移动应用程序可用于监测和管理心理健康症状或障碍。然而,大多数应用程序的临床验证证据尚不清楚;因此,长期使用这些应用程序对患者的益处存在争议。
本次更新的综述旨在系统评估所有年龄段的心理健康移动应用程序的疗效和可接受性的现有研究证据。
对 PubMed、Cochrane 图书馆、EMBASE、Web of Science 和 Google Scholar 进行了全面的文献检索(2013 年 5 月至 2017 年 12 月)。如果摘要描述了针对所有年龄段的移动设备提供的心理健康应用程序(针对抑郁、焦虑、双相情感障碍、精神病、创伤后应激障碍 (PTSD)、物质使用障碍、睡眠障碍和自杀行为),则将其纳入。
共确定了 1501 篇摘要。其中,有 17 篇文献描述了针对焦虑/压力、酒精障碍、睡眠障碍、抑郁、自杀行为和 PTSD 的 16 个应用程序符合纳入标准。有 5 项研究将个体随机分配到试验条件下,有 14 个应用程序被证明在减轻心理健康症状或障碍方面具有临床验证证据。
心理健康应用程序在改善心理健康症状或障碍的监测和管理方面具有潜力。然而,目前大多数可用的应用程序缺乏其疗效的临床验证证据。鉴于移动健康 (mHealth) 应用程序的数量和发布速度,需要进一步进行强有力的研究,以开发和测试基于证据的程序。